Literature DB >> 16244260

Cirrhotic nodules: association between MR imaging signal intensity and intranodular blood supply.

Rieko Shinmura1, Osamu Matsui, Satoshi Kobayashi, Noboru Terayama, Junichiro Sanada, Kazuhiko Ueda, Toshifumi Gabata, Masumi Kadoya, Shiro Miyayama.   

Abstract

PURPOSE: To retrospectively determine whether there is a relationship between the intranodular blood supply evaluated at computed tomography (CT) during arterial portography (CTAP) and CT during hepatic arteriography (CTHA) and the magnetic resonance (MR) imaging signal intensity of nodules associated with cirrhosis.
MATERIALS AND METHODS: Neither institutional review board approval nor informed consent was required for retrospective reviews of medical records and images. One hundred fourteen hepatocellular nodules 10 mm or greater in largest diameter in 58 patients (39 men, 19 women; mean age, 61 years) with cirrhosis were evaluated at CTAP, CTHA, and MR imaging. The CTAP and CTHA nodule findings were divided into three main types: Type A nodules were isoattenuating at CTAP and hypoattenuating at CTHA; type B nodules, slightly hypoattenuating at CTAP and hypoattenuating at CTHA; and type C nodules, strongly hypoattenuating at CTAP and hyperattenuating at CTHA. The relationships between the CTAP and CTHA findings and the MR imaging signal intensity among these nodules were analyzed by using the chi(2) test.
RESULTS: On T1-weighted MR images, 27 (63%) of 43 type A nodules were hyperintense, nine (39%) of 23 type B nodules were isointense, and 19 (48%) of 40 type C nodules were hypointense; differences were not significant. On T2-weighted MR images, 31 (72%) of 43 type A nodules were hypointense (P < .05), 12 (52%) of 23 type B nodules were isointense, and 34 (85%) of 40 type C nodules were hyperintense (P < .05).
CONCLUSION: There was a significant association between intranodular blood supply and nodule signal intensity on T2-weighted MR images. However, study findings did not show whether the blood itself (ie, blood volume or blood flow amount) directly influenced the signal intensity.

Entities:  

Mesh:

Year:  2005        PMID: 16244260     DOI: 10.1148/radiol.2372041389

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  22 in total

1.  Outcomes of follow-up CT for small (5-10-mm) arterially enhancing nodules in the liver and risk factors for developing hepatocellular carcinoma in a surveillance population.

Authors:  Min Jung Park; Young-Sun Kim; Won Jae Lee; Hyo K Lim; Hyunchul Rhim; Jongmee Lee
Journal:  Eur Radiol       Date:  2010-06-19       Impact factor: 5.315

2.  Incidence for progression of hypervascular HCC in hypovascular hepatic nodules showing hyperintensity on gadoxetic acid-enhanced hepatobiliary phase in patients with chronic liver diseases.

Authors:  Megumi Matsuda; Takaharu Tsuda; Shinji Yoshioka; Shigetoshi Murata; Hiroaki Tanaka; Masashi Hirooka; Yoichi Hiasa; Teruhito Mochizuki
Journal:  Jpn J Radiol       Date:  2014-05-24       Impact factor: 2.374

3.  Performance of radiological methods in diagnosing hepatocellular carcinoma preoperatively in a recipient of living related liver transplantation: comparison with step section histopathology.

Authors:  Masakazu Hirakawa; Kengo Yoshimitsu; Hiroyuki Irie; Tsuyoshi Tajima; Akihiro Nishie; Yoshiki Asayama; Kousei Ishigami; Daisuke Kakihara; Akinobu Taketomi; Shin-ichi Aishima; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2011-02-27       Impact factor: 2.374

4.  MR Imaging Grading System for Skull Base Chordoma.

Authors:  K Tian; L Wang; J Ma; K Wang; D Li; J Du; G Jia; Z Wu; J Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-20       Impact factor: 3.825

5.  Diagnostic efficacy of gadoxetic acid-enhanced MRI for hepatocellular carcinoma and dysplastic nodule.

Authors:  Kazuhiro Saito; Fuminori Moriyasu; Katsutoshi Sugimoto; Ryota Nishio; Toru Saguchi; Toshitaka Nagao; Junichi Taira; Soichi Akata; Koichi Tokuuye
Journal:  World J Gastroenterol       Date:  2011-08-14       Impact factor: 5.742

Review 6.  Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRI.

Authors:  Alexander Kagen; Kathryn Fowler; Claude B Sirlin
Journal:  Hepat Oncol       Date:  2013-12-20

7.  Role of Diffusion Weighted Imaging (DWI) for Hepatocellular Carcinoma (HCC) Detection and its Grading on 3T MRI: A Prospective Study.

Authors:  Shiva Shankar; Naveen Kalra; Anmol Bhatia; Radhika Srinivasan; Paramjeet Singh; Radha K Dhiman; Niranjan Khandelwal; Yogesh Chawla
Journal:  J Clin Exp Hepatol       Date:  2016-09-01

8.  [Rational imaging of hepatocellular carcinoma. The challenge of multimodal diagnostic criteria].

Authors:  A Kircher; G Bongartz; E M Merkle; C J Zech
Journal:  Radiologe       Date:  2014-07       Impact factor: 0.635

9.  Differentiating malignant from benign hyperintense nodules on unenhanced T1-weighted images in patients with chronic liver disease: using gadoxetic acid-enhanced and diffusion-weighted MR imaging.

Authors:  Ji Yoon Moon; Seong Hyun Kim; Seo-Youn Choi; Jeong Ah Hwang; Ji Eun Lee; Jisun Lee
Journal:  Jpn J Radiol       Date:  2018-06-06       Impact factor: 2.374

10.  Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging.

Authors:  Chen-Te Chou; Jung-Mao Chou; Ting-An Chang; Shiu-Feng Huang; Chia-Bang Chen; Yao-Li Chen; Ran-Chou Chen
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.